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Abstract
Choroidal neovascularization (CNV) is the common pathological basis of irreversible visual impairment encountered in a
variety of chorioretinal diseases; the pathogenesis of its development is complicated and still imperfectly understood.
Recent studies indicated that delta-like ligand 4 (Dll4), one of the Notch family ligands might participate in the HIF-1a-VEGF
pathway to regulate CNV angiogenesis. But little is known about the influence and potential mechanism of Dll4/Notch
signals on CNV angiogenesis. Real-time RT-PCR, Western blotting were used to analyze the expression alteration of Dll4,
VEGF and HIF-1a in hypoxic RF/6A cells. Immunofluorescence staining, a laser-induced rat CNV model and intravitreal
injection techniques were used to confirm the relationships among these molecules in vitro and in vivo. RPE-RF/6A cell co-
culture systems were used to investigate the effects of Dll4/Notch signals on CNV angiogenesis. We found that the Dll4 was
involved in hypoxia signaling in CNV angiogenesis. Results from the co-culture system showed that the enhancement of
Dll4 expression in RF/6A cells led to the significantly faster proliferation and stronger tube forming ability, but inhibited cells
migration and invasion across a monolayer of RPE cells in hypoxic environment, while siRNA-mediated Dll4 silencing caused
the opposite effects. Pharmacological disruption of Notch signaling using gamma-secretase inhibitor (GSI) produced similar,
but not identical effects, to that caused by the Dll4 siRNA. In addition, the expression of several key molecules involved in
the angiogenesis of CNV was altered in RF/6A cells showing constitutively active Dll4 expression. These results suggest that
Dll4 play an important role in CNV angiogenesis, which appears to be regulated by HIF-1a and VEGF during the progression
of CNV under hypoxic conditions. Targeting Dll4/Notch signaling may facilitate further understanding of the mechanisms
that underlie CNV angiogenesis.
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Introduction
Choroidal neovascularization (CNV), which involves both
angiogenesis and vasculogenesis, occurs as the final event in a
variety of chorioretinal diseases, causing severe and irreversible
loss of vision. In recent decades, significant progress has been
made in studies on the pathophysiologic mechanisms linked to
CNV. However, the development of CNV is a complex and
dynamic process, including multi-stimuli, multi-cytokines and
multi-cells participate in, the specific mechanism underlying its
progression is still poorly understood [1].
It has been recognized that disruption of the balance of
angiogenesis promoters and inhibitors initiates CNV growth.
Vascular epithelium growth factor (VEGF) is believed as the most
powerful angiogenesis promoter, and played the significant role in
the development and maintenance of the choroidal vasculature
[2]. Pathogenesis investigation and therapy targeting VEGF in
CNV have been made a lot of achievements [3]. Like VEGF, there
are some molecules not only occupy an important position in
embryonic vascular development, but also in adult angiogenesis.
Among of them, Dll4/Notch has attracted extensive attention
recently [4,5].
Dll4 is one of the Notch ligands in mammalian cells, and is
expressed specifically in the physiological and pathological
vasculature [6]. Remarkably, the deletion of a single Dll4 allele
resulted in early embryonic lethality due to the failure to form a
functional vasculature [7,8]. So far, only two genes, Dll4 and
VEGF, are known to cause embryonic lethality due to haploin-
sufficiency, which emphasizes their crucial role in vascular
development [9].
Flurry of publications yielded substantial insights into the
important role of Dll4 in angiogenesis. During early development,
Dll4 was expressed specifically in arterial endothelial cells (ECs) of
the embryonic vasculature and developing retinal arteries to
regulate vascular arterializations [6,10,11]. In the angiogenesis of
the adult and tumors vascular network, Dll4 had been shown to
regulate tip/stalk cell specification, and the attenuation of Dll4/
Notch signaling resulted in a chaotic vascular network with
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interacted with VEGF signaling on several levels to regulate
angiogenesis. It functioned downstream of VEGF signaling and its
activation triggered a negative feedback loop that restrains the
effects of VEGF [13,14].
Our previous study had found that disruption of the
transcription factor recombination signal-binding protein Jk
(RBP-J), the key transcription factor in Notch signaling, resulted
in a more severe neovascularization at the site of laser-induced
CNV. In addition, in the absence of RBP-J, proliferation of ECs
increased significantly, leading to accumulative vessel outgrowth
[15]. These findings suggested that Notch signaling may regulate
angiogenesis of CNV by effecting on the activity of ECs.
Nevertheless, the precise mechanism underlying the effects has
not yet been known.
Age-related changes and stimulus underlying ocular diseases
often cause hypoxia in the microenvironment surrounding the
retina, Bruch’s membrane and the choriocapillaris [1]. Under
hypoxic conditions, retinal pigment epithelial (RPE) cells could
activate hypoxia inducible factor 1a (HIF-1a) pathway to release
angiogenesis promoters like VEGF [16,17,18], then the signaling
through VEGF receptors and EphrinB2/EphB4 signal systems
influenced choroidal microvascular endothelial cells (CECs)
function to initiate the angiogenesis of CNV [19]. In addition,
previous reports demonstrated that Dll4 was a hypoxia-regulated
gene, which not only received signals from HIF-1a in ECs, but
also responded to HIF-1a-VEGF signaling via the hypoxia
pathway [20,21,22]; VEGF receptors and EphrinB2 were direct
target genes regulated by Dll4 [23,24,25]. Combining these
results, we hypothesized that Dll4/Notch signaling might
participate in the HIF-1a-VEGF pathway to regulate CNV
angiogenesis in pathologic retinochoroidal diseases.
In the present study, rhesus macaque RF/6A cells were
employed to represent CECs, as they are convenient for
experimental manipulation and share a high level of evolutionary
conservation with humans. The chemical hypoxia model was
established in RF/6A cells to investigate the influence of Dll4/
Notch signaling on the HIF-1a-VEGF pathway and an RPE-RF/
6A contacting/separating co-culture system was used to explore
the role of Dll4/Notch signaling in regulating the key step in CNV
angiogenesis. The results showed that Dll4 was a vascular
regulator involved in CNV angiogenesis, and that it was regulated
by HIF-1a and VEGF during CNV progression under hypoxic
conditions. Our results provide a novel molecular mechanism for
CNV and present a new potential target for CNV treatment in the
future.
Results
Up-regulation of Dll4 expression in RF/6A cells under
hypoxic condition
To explore the possibility that Dll4 may participate in hypoxia-
mediated signaling in CNV, we investigated the effects of chemical
hypoxia on Dll4 expression in RF/6A cells. As expected, real-time
RT-PCR showed that Dll4 mRNA transcription increased
significantly after 6 hrs of hypoxia and slowly declined thereafter
(Fig. 1A). As shown by Western blotting (Fig. 1B), Dll4 protein
levels in RF/6A cells were also up-regulated during hypoxia. The
time course of the Dll4 protein expression profile (Fig. 1C)
mirrored that for Dll4 mRNA (Fig. 1A) in hypoxic RF/6A cells.
Figure 1. Quantitative analysis of the expression of Dll4, HIF-1a and VEGF by real-time RT-PCR and Western blotting in hypoxic RF/
6A cells. Messenger RNA (A) and protein (B) expression of Dll4, HIF-1a and VEGF in RF/6A cells under hypoxia induced by 200 mM CoCl2 at 6, 12, 24
and 48 hrs, with 0 h as the baseline. (C) The time course of Dll4, HIF-1a and VEGF protein expression in RF/6A cells under hypoxia was consistent with
the mRNA (#P,0.05, *P,0.01).
doi:10.1371/journal.pone.0018481.g001
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with Dll4 expression and the results showed that the variation in
Dll4 expression was in accordance with variations in HIF-1a and
VEGF levels (Fig. 1).
Reduced expression of Dll4 and VEGF by transfection of
pshHIF-1a to RF/6A cells under hypoxia
To confirm further whether Dll4 is regulated by HIF-1a in RF/
6A cells under hypoxia, Dll4 mRNA and protein expression was
measured in RF/6A cells transfected with pshHIF-1a under
hypoxic conditions for 6 hrs. In pshHIF-1a-transfected RF/6A
cells, the up-regulation of HIF-1a, induced by CoCl2, was
abolished, while no effect was seen in cells transfected with the
control pDNA (Fig. 2). Real-time RT-PCR results revealed that
the up-regulation of Dll4 expression under hypoxia was preserved
in the control transfection, but disappeared in the pshHIF-1a
group (Fig. 2A). The data from the Western blotting analysis was
consistent with this finding (Fig. 2B and C). At the same time,
VEGF mRNA and protein expression was inhibited in a similar
fashion after CoCl2 treatment in the pshHIF-1a-transfected RF/
6A cells (Fig. 2), indicating that both Dll4 and VEGF were HIF-
1a-regulated genes.
Downstream location of Dll4 of the VEGF in CNV
angiogenesis
The next question was to determine whether Dll4 was regulated
by VEGF in ocular ECs. VEGF165 was added exogenously to the
culture medium of RF/6A cells and the resulting immunofluores-
cence images confirmed that Dll4 expression was induced by
VEGF in RF/6A cells (Fig. 3).
Simultaneously, we found that the up-regulation of Dll4 after
laser photocoagulation in the laser-induced rat CNV model could
be inhibited by intravitreal injection of the VEGF inhibitor,
Figure 2. Effect of psh-HIF-1a on hypoxia-induced Dll4, HIF-1a and VEGF expression in RF/6A cells determined by real-time RT-
PCR and Western blotting. Messenger RNA (A) and protein (B and C) expression of Dll4, HIF-1a and VEGF in RF/6A cells transfected with either
psh-HIF-1a or control pDNA. RF/6A cells were exposed to 200 mM CoCl2 for 6 hrs to achieve chemical hypoxia. After 6 hrs exposure to hypoxia, Dll4,
HIF-1a and VEGF expression increased in RF/6A cells transfected with control pDNA (*1 P,0.01). While transfected with psh-HIF-1a, the up-regulation
of Dll4, HIF-1a and VEGF in RF/6A cells by hypoxia were abrogated (*2 P,0.01).
doi:10.1371/journal.pone.0018481.g002
Figure 3. Representative immunofluorescence images of Dll4
in RF/6A cells stimulated by VEGF165. CY3 (red)-conjugated
secondary antibody represented Dll4 expression (A and D), DAPI
(blue)-stained nuclei (B and E). (C) Merged image of A and B. (F) Merged
image of D and E. The results clearly showed that Dll4 expression was
induced by VEGF165 (D–F) compared with the PBS-treated control group
(A–C). Bar=50 mm.
doi:10.1371/journal.pone.0018481.g003
Mechanism of Dll4 in CNV Angiogenesis
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was located downstream of VEGF in CNV angiogenesis.
Promotion of RF/6A cells proliferation by Dll4 in a
co-culture system under hypoxia
Next, an RPE-RF/6A co-culture system was utilized to
investigate the precise effects of Dll4, induced by RPE cells under
conditions of chemical hypoxia, on RF/6A cells function. A
proliferation assay showed that constitutive expression of Dll4 in
RF/6A cells significantly increased cell proliferation under
hypoxia in the co-culture system, compared to control pDNA-
transfected cells. By contrast, cells proliferation was suppressed by
silencing Dll4 expression in hypoxic RF/6A cells using the Dll4-
specific siRNA, Si-D114. To confirm that the Dll4 defect in RF/
6A cells was consistent with a disruption in Notch signaling, GSI
treatment was used to disrupt Notch signaling pharmacologically.
Interestingly, in this experiment, the suppression of cell prolifer-
ation was significantly greater than in Si-Dll4-treated cells under
hypoxic conditions (Fig. 5).
Inhibition of RF/6A cells migration by Dll4 in a co-culture
system under hypoxia
The effects of Dll4 on RF/6A cells migration in a co-culture
system under hypoxia were also investigated. The number of RF/
6A cells, transfected with Dll4, which migrated across the insert,
was reduced by 50.6% compared with the control pDNA group,
while the RPE-/hypoxia-induced RF/6A cells migration increased
remarkably by 41.4% in Si-Dll4-transfected RF/6A cells.
However, the blockade of Notch signaling via GSI treatment
attenuated cells migration by 55.2% (Fig. 6).
Promotion of RF/6A cells tube formation by Dll4 in a
co-culture system under hypoxia
Tube formationisa veryimportantfunctionofECs.RF/6Acells,
transfected with Dll4, and grown in a collagen matrix gel under
hypoxiashowed enhanced tube formationability. This result agreed
withthe proliferation assay,sincetheability ofECstoform tube-like
structures is partly related to cell proliferation. When Dll4
expression was inhibited or Notch signaling was blocked in RF/
6A cells, tube formation was reduced significantly (Fig. 7).
Inhibition of RF/6A cells invasion by Dll4 across the RPE
monolayer under hypoxia
The rupture of Bruch’s membrane by CECs and their migration
through the RPE monolayer into the neurosensory retina is a
complex and important process in the development of CNV. To
determine whether Dll4 influences the invasion of RF/6A cells across
an RPE monolayer, a contact co-culture system was used under
hypoxic conditions to investigate the hypothesis. After GFP-labeled
RF/6A cells were placed in contact with an RPE monolayer plated
o nt h eu n d e r s i d eo ft h em e m b r a n ef o r4h r s ,t h en u m b e ro fi n v a d e d
RF/6Acells wasquantified and theresultsshowed that the numberof
cells that over-expressed Dll4 was significantly lower than the number
of pDNA-transfected cells. The number of invaded cells was highest
in the Si-Dll4 group, with slightly fewer migrated cells in the GSI
treated group compared to the control (Fig. 8).
Alterations of the expression of several critical genes by
Dll4 constitutive over-expression in RF/6A cells
Real-time RT-PCR was used to assess further the effects of
over-expressing Dll4 on key CNV angiogenesis genes downstream,
Figure 4. Expression of VEGF and Dll4 by intravitreal injection of Avastin in a laser-induced rat CNV model determined by RT-
PCR and Western blotting. Messenger RNA expression (A and B) and protein expression (C and D) of VEGF and Dll4 in the experimental CNV
model. Compared with the PBS-treated group, VEGF (*1 P,0.01) and Dll4 expression clearly decreased by intravitreal injection of Avastin.
doi:10.1371/journal.pone.0018481.g004
Mechanism of Dll4 in CNV Angiogenesis
PLoS ONE | www.plosone.org 4 April 2011 | Volume 6 | Issue 4 | e18481including VEGFR1, VEGFR2, EphrinB2 and EphB4. Up-
regulating Dll4 by 4.3-fold led to a 5.9-fold increased in VEGFR1
expression and a 2.9-fold increased in EphrinB2 expression, but an
5.7-fold decreased in VEGFR2 expression and a 1.4-fold
decreased in EphB4 expression (Fig. 9). These changes in gene
expression might contribute to variations in RF/6A cells behavior.
Discussion
In the past, it has been generally accepted that the Notch
pathway is an evolutionarily conserved signaling system required
for normal embryonic development, the regulation of tissue
homeostasis, and the maintenance of stem cells in adults [26,27].
Notch signaling is initiated by the cleavage of the Notch
intracellular domain (NICD) activated through ligand-receptor
binding on cells membrane, then NICD immediately translocates
to the nucleus where it interacts with transcription factors and
regulates downstream genes expression, such as HES1, HES5, and
HEY1 [26,28]. Nonetheless, the essential contribution of the
Notch pathway to vascular morphogenesis has been revealed only
recently [4,5,29]. There are five transmembrane Notch ligands
(Jagged1, Jagged2, Dll1, Dll3, and Dll4) and four Notch receptors
(Notch1- to 4) in mammalian cells. Of note, the expressions of Dll4
and its acknowledged known receptors (Notch1 and Notch4) are
relatively restricted to the vascular system, where several studies
have shown that Dll4/Notch signaling is crucial [7,8,30,31].
During early embryonic development, Dll4 expression was
initially observed in the major arterial vessels. With embryonic
maturation, this pattern of expression disappeared and became
confined to the small vessels and capillaries. Consistent with the
restricted expression pattern of Dll4, it had been demonstrated
that Dll4/Notch signaling played a critical role in arteriovenous
specification [32], acting downstream of VEGF to regulate the
expression of the arterial marker EphrinB2 [24,25]. In the studies
of mouse retinal vasculature, Dll4 expression was mainly confined
to the tip cells, and also endogenously distributed to the stalk cells,
capillary plexus, arterial endothelium and capillary pericytes
[11,33]. Genetic and pharmacological inactivation of Dll4/Notch
led to the formation of a highly branched and dense vascular
network, however, the vascular structures were often not fully
lumenized, generating nonproductive vessels, which indicated that
both permissive and suppressive signals within the growing sprout
were required for the formation of an effective vascular network
[34,35]. Therefore, Dll4 seemed to act as a caretaker, which
ensured that vascularization under control, and promoted the
temporal and spatial organization of a functional vasculature.
The retina is very sensitive to hypoxia. More recently it has been
suggested that choroidal circulation altered in patients with age-
related macular degeneration (AMD), thus resulting in a hypoxic
environment surrounding the endothelium, which could change
the levels of pro-angiogenic factors [36]. Retinal hypoxia
stimulated HIF-1a activation and enhanced the transcription
and secretion of VEGF [16]. Under hypoxic conditions, RPE cells
induced the alteration of migration and proliferation of the
choroidal ECs and also affected the formation of new capillary
tubes [19,37]. In this study, we have confirmed that Dll4 was a
hypoxia-regulated gene, which was consistent with the previous
studies [20,21,22]. Our data revealed that the expression of Dll4
both on mRNA and protein level significantly increased in a time-
dependent manner following HIF-1a and VEGF activation
responded to the chemical induced hypoxia in RF/6A cells,
which was the first quantitative evaluation of the frequency and
extent of Dll4 up-regulation in ocular ECs.
Figure 5. Analysis of effect of Dll4 on the proliferation of RF/6A cells co-cultured with RPE cells under hypoxia by MTT proliferation
assay. RF/6A cell growth curves from five treatment groups are depicted. In the proliferation assay, hypoxia increased RF/6A cells proliferation in the
co-culture system, while the up-regulation of Dll4 in RF/6A cells promoted cell growth to a remarkable extent (*1 P,0.01 vs control pDNA-transfected
group under hypoxia). By contrast, cell growth was suppressed significantly by the silencing of Dll4 (*2 P,0.01) and by the total block of Notch
signaling in GSI-treated cells (*3 P,0.01). Noticeably, the proliferation of GSI-treated cells was even lower than that of Si-Dll4-transfected cells (*4
P,0.01 vs Si-Dll4-transfected group under hypoxia).
doi:10.1371/journal.pone.0018481.g005
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either directly by hypoxia [20,22], or directly in response to the
release of other hypoxia-induced factors, such as VEGF [38],
recapitulating it can participate in hypoxia-mediated signal
pathway to regulate CNV. Consistent with this hypothesis, our
data showed the hypoxic regulation of Dll4 was dependent on
HIF-1a. When HIF-1a was silenced by HIF-1a shRNA
transfection in RF/6A cells, the up-regulation of Dll4 and VEGF
induced by CoCl2 were both abolished. Next, to test whether Dll4
expression depended on VEGF signaling, soluble VEGF165 was
added to the culture medium of RF/6A cells. The results verified
that Dll4 expression did, indeed, increase following VEGF
stimulation. To confirm that the up-regulation of Dll4 was still
required VEGF signaling, the CNV model in vivo was used. The
data revealed that intravitreous injection of Avastin in rat CNV
model, not only inhibited VEGF ocular expression, but also
suppressed the mRNA and protein expression of Dll4, as shown in
a previous study [38], implying that VEGF acted as the upstream
of Dll4 in CNV angiogenesis. It had also been reported that the
up-regulation of Dll4 by VEGF was mediated by both VEGFR1
and VEGFR2, which was dependent on phosphatidylinositol 3-
kinase/Akt pathway but not MAPK/ERK or src kinases [39].
Notably, VEGF induction of Dll4 was demonstrated in the mouse
retina recently [38]. Injection of VEGF164 into the vitreous
increased expression of Dll4 in retinas, whereas injection of the
VEGF antagonist VEGF-Trap reduced the expression of Dll4.
The current data provided evidence that Dll4/Notch signaling
might play important role in the HIF-1a-VEGF pathway to
regulate the progression of CNV under hypoxic conditions.
Therefore, we investigated the exact effects of Dll4 in CNV
angiogenesis. Different co-culture systems were utilized to observe
the effects of RPE cells on CECs under CoCl2 treated hypoxia.
Our findings showed that up-regulation of Dll4 expression in RF/
6A cells resulted in a significant increase in proliferation and tube
formation, but inhibited cell migration, while the silencing of Dll4
had the opposite effect. It was previously shown that up- or down-
regulation of Dll4 in different ECs lines reduced cell proliferation,
Figure 6. Analysis of effect of Dll4 on the migration of RF/6A
cells co-cultured with RPE cells under hypoxia by transwell
migration assay. (A) HE staining reveals migrated cells from each of
the following groups: co-cultured RF/6A cells transfected with control
pDNA group under hypoxia, Dll4 up-regulation group, Dll4 down-
regulation group and GSI treated group. (B) The number of RF/6A cells
that had migrated was reduced significantly by 50.6% in the group
transfected with Dll4, but was increased by 41.4% in the Si-Dll4
transfected group, and was attenuated by 55.2% in the GSI treated
group (* P,0.01) compared with the control pDNA group. Bar=50 mm.
doi:10.1371/journal.pone.0018481.g006
Figure 7. Analysis of effect of Dll4 on tube formation of RF/6A
cells co-cultured with RPE cells under hypoxia by tube
formation assay. (A) Microscopic images showing tube formation in
each of the four treatment groups: co-cultured RF/6A cells transfected
with control pDNA under hypoxia, Dll4 up-regulation group, Dll4 down-
regulation group and GSI treated group. (B) Increased tube formation
was observed when co-cultured RF/6A cells were transfected with Dll4
under hypoxia (*P,0.01 vs control pDNA transfected group). By
contrast, reduced tube formation was seen in co-cultured RF/6A cells
with down-regulated Dll4 and in cells subjected to pharmacological
disruption of Notch signaling (*P,0.01). Bar=100 mm.
doi:10.1371/journal.pone.0018481.g007
Mechanism of Dll4 in CNV Angiogenesis
PLoS ONE | www.plosone.org 6 April 2011 | Volume 6 | Issue 4 | e18481migration, and tube-like formation [22,40,41]. Thus, the effects of
Notch signaling seemed to depend on species, microenvironment
and specific cell type. During the process of CNV development,
CECs not only migrate towards the chemotactic gradients
produced by RPE cells, but also invade across the RPE monolayer
at a later stage. It has been reported that CEC-RPE contact-
induced disruption of RPE barrier properties occurred in CNV. In
this situation, CECs migrated through Bruch’s membrane and
came into contact with the RPE, leading to further exacerbation of
the already compromised blood-retinal barrier [42,43]. However,
little is known about the interactions between RPE cells and CECs
and the signaling events that lead to CECs transmigration. The co-
culture contact results reported in this study showed that Dll4
inhibited the invasion of RF/6A cells across the RPE monolayer.
According to the results, Dll4/Notch signaling might involve in
CNV angiogenesis.
In addition, whenever we pharmacologically disrupted the
Notch signaling using GSI, the proliferation, tube formation,
migration, and even invasion across RPE monolayer of RF/6A
cells were inhibited, indicating that Notch signaling promote the
procession of CNV angiogenesis. It is very noticed that the
inhibition effect on CNV angiogenesis by GSI was not identical to
what caused by Dll4 siRNA. These results indicated that the effect
of Notch signaling on CNV angiogenesis was not only through
Dll4 ligand pathway, although Dll4 was the most studied vascular
regulator in Notch family. Researchers previously reported the
important differences in the cellular distribution of Notch ligands
during the vascular development of the retina [11]. For example,
Jagged1, another critical component in the process of tip cell
selection, which antagonizes Dll4/Notch signaling during angio-
genesis, was detected in stalk cells, where Dll4 was absent [44].
These findings indicated distinct roles for Notch signaling during
the angiogenic process of CNV.
Furthermore, we found that constructive expression of Dll4 in
RF/6A cells altered the transcription of several important genes
that regulate angiogenesis. Real-time RT-PCR revealed that the
expression of the arterial marker genes, EphrinB2 and VEGFR1,
was up-regulated in Dll4-transfected RF/6A cells, while the
expression of VEGFR2 and EphB4 was down-regulated. These
results indicated that the functional alteration of RF/6A cells
might be due to the diverse effects of Dll4/Notch signaling on
different vascular genes [19]. Consistent with our findings, other
groups have verified that Dll4/Notch signaling acts in a negative
feedback loop with VEGF since Notch signaling represses
transcription of the VEGFR2 gene through upregulation of its
target gene, HESR1 (HEY1) [23,38,45]. The feedback effect
between Dll4 and VEGF appeared vitally important for the
selection of tip-stalk cells, a key step in angiogenesis, which
occurred during the angiogenic expansion, in which vascular
sprouts were guided by the migration of tip cells in response to the
graded distributions of matrix-bound VEGF.
Figure 8. Analysis of effect of Dll4 on invasion of RF/6A cells
across RPE monolayer under hypoxia in a contact co-culture
system. Representative photographs of each group are shown. (A)
RPE-RF/6A contact co-culture system. (B) GFP-labeled migrated RF/6A
cells from each of the following groups: co-cultured cells transfected
with control pDNA, Dll4 up-regulation group, Dll4 down-regulation
group and GSI treated group. (C) The number of invaded RF/6A cells
overexpressing Dll4 was significantly reduced compared with the
control, as was the number of invaded cells in the GSI-treated group;
however, the Si-Dll4 transfected group showed a noticeable increasing
in invasion (# P,0.05, * P,0.01). Bar=100 mm.
doi:10.1371/journal.pone.0018481.g008
Figure 9. Quantitative analysis of the expression of several
critical genes by real-time RT-PCR in constitutive up-regulation
of Dll4 in RF/6A cells. The expression of VEGFR1 and EphrinB2
increased, but VEGFR2 and EphB4 decreased significantly in over-
expression of Dll4 in RF/6A cells.
doi:10.1371/journal.pone.0018481.g009
Mechanism of Dll4 in CNV Angiogenesis
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mechanisms in a series of chorioretinal diseases causing severe
and irreversible visual loss, like AMD. However, the treatment of
CNV was depressed by its complicated and poorly understood
pathogenesis. Until now, the main focus of drug target
development for AMD was the inhibition of VEGF, due to its
key role in CNV. Although the early success of anti-VEGF therapy
for neovascular AMD was certainly encouraging, the effects of
long-term VEGF inhibition will require close monitoring. In
addition, anti-VEGF therapy alone appears to be ineffective in
most cases [3], additional factors or pathways that drive
angiogenesis directly, or switch on at certain stages to regulate
angiogenesis, need to be pursued. In our study, we have
demonstrated that Dll4/Notch signaling played a role in CNV
angiogenesis, which appears to be regulated by HIF-1a-VEGF
signaling during the progression of CNV under hypoxic
conditions. Although the contribution of Notch signaling to
vascular homeostasis is complicated and remains yet to be fully
understood, our findings may facilitate further understanding of
the mechanisms that underlie CNV angiogenesis and provide an
innovative treatment strategy for ocular angiogenesis.
Materials and Methods
Cell culture and chemical hypoxia model
The Rhesus macaque choroid-retinal EC line, RF/6A, was
obtained from the cell bank at the Chinese Academy of Science
(CAS) and cultured according to their directions and guidance.
RPE cells were obtained from a mature cell line preserved in our
laboratory, and the cells were cultured as described previously
[46]. For the hypoxia treatment, 200 mM CoCl2 was added to the
culture medium, and cells were harvested after 6, 12, 24 and
48 hrs. Data from cells cultured under normoxic conditions were
regarded as the baseline and were defined as hypoxia o h.
In vitro transfection
RF/6A cells (1.0610
6 per well) were plated in six-well plates
(Corning, Costar, US). After an overnight incubation in
Dulbecco’s modified Eagle’s Medium (DMEM), containing 10%
fetal bovine serum (FBS) without antibiotics, transfection of the
following constructs: a plasmid exhibiting constitutive expression
of human full length Dll4 (pShuttle-CMV-hDll4) and its control
plasmid, pShuttle-CMV (kind gifts from professor HanHua); a
plasmid containing HIF-1a short hairpin RNA (shRNA) (Gene-
chem, Shanghai, China, previously described in detail [19]),
pshHIF-1a, and pcDNA3.1+ transcribing as non-related sequence
to pshHIF-1a; Dll4 siRNA, Si-Dll4 (F: gugggucagaacugguuauTG,
R: auaaccaguucugacccacCC, Biomics, US), was performed using
Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to
the manufacturer’s instructions. In brief, for 6-well plates, 2.5 mg
pDNA was mixed with 5 ml Lipofectamine 2000 at a final
concentration of 1.3 mg pDNA/ml, dissolved in DMEM without
serum, the resulting complex was added to the cells, which were
then incubated for 4 to 6 hrs. Next, the cells were washed with
DMEM and incubated in DMEM with 10% FBS for a further
24 hrs until used. The amounts of siRNA and transfection agent
used were optimized, and over 80% transfection efficiency was
observed, using fluorescence microscopy, with little to no toxicity
visible under a light microscope and optimal conditions.
Experimental CNV model and intravitreal injection
Laser-induced CNV model of Brown Norway rats, weighing
200 to 250 g each, was performed as previously described
[47,48,49]. Briefly, recipient rats were anesthetized, and their
pupils were dilated. Laser photocoagulation (532 nm wavelength,
75 mm spot size, 0.1 second duration, and 150 mW intensity) was
delivered with a slit lamp and a cornea contact lens. Eight to ten
laser photocoagulations were performed in each eye between the
major retinal vessels of the superior retina. Only laser spots where
rupture of Bruch’s membrane was confirmed with a vaporization
bubble without hemorrhage were considered effective and
included in the study. Intravitreal injection of 10 ml of Avastin
solution (25 mg/ml) per rat eye was performed immediately after
CNV induction as previously described [50,51]. Injection of 10 ml
of PBS served as the control.
All the experimental procedures were conducted in accordance
with the Detailed Rules for the Administration of Animal
Experiments for Medical Research Purposes issued by the
Ministry of Health of China, and were received ethical approval
(Permit number: 11003) by the Animal Experiment Administra-
tion Committee of Fourth Military Medical University (Xi’an, P.
R. China). All efforts were made to minimize animals’ suffering
and to reduce the number of animals used.
Real-time and semi-quantitative RT-PCR analysis
RNA, extracted from cells with Trizol reagent (Invitrogen, Life
Technologies, US), was converted to cDNA with the RevertAid
TM
First Strand cDNA Synthesis Kit (Fermantas, CA). Real-time PCR
was performed using the ABI PrismH 7500 Real-Time PCR
Detection System (ABI, US) and the SYBRH Premix Ex Taq
TM II
Kit (Takara, Japan) according to the manufacturer’s instructions.
The relative gene expression levels were calculated using the 2-
DDCt method, where Ct represents the threshold cycle, and
GAPDH was used as a reference gene. The primer sequences are
shown in Table 1.
For the animal experiments, total RNA was prepared from four
eyecups (RPE-choroid-sclera complex) from each group 7 days
after photocoagulation. The PCR-amplified products were
visualized via agarose gel (1%) electrophoresis and band intensities
were quantitated using Kodak Digital Science one-dimensional
software (Eastman Kodak Co., New Haven, CT). The intensity of
the band in each lane was normalized to the intensity of b-Actin.
The primer sequences used are shown in Table 2.
Western blot analysis
RF/6A cells and rat tissue samples from the RPE-choroidal
complexes were homogenized in RIPA lysis buffer and insoluble
material was removed by centrifugation at 4uC. Forty micrograms
of total protein extract from each sample were resolved by 10%
SDS-PAGE and transferred to nitrocellulose membranes (Amer-
sham Biosciences). The membranes were blocked in 5% milk and
probed with the following antibodies: goat polyclonal anti-Delta-4
(1:5000, Santa Cruz Biotech, Santa Cruz, CA, USA), mouse
monoclonal anti-HIF-1a (1:2000, Chemicon, Temecula, CA,
USA) or mouse monoclonal anti-VEGF (1:1500, Santa Cruz
Biotech, Santa Cruz, CA, USA) overnight at 4uC. Membranes
were washed and incubated with a horseradish peroxidase (HRP)-
conjugated secondary antibody (Santa Cruz Biotech, Santa Cruz,
CA, USA) for 1 h at 37uC. The addition of chemiluminescent
HRP substrate solution (Millipore, USA) was used to develop the
images.
Immunofluorescence staining
RF/6A cells were allowed to adhere to glass coverslips at the
bottom of 24-well plates for 12 hrs. For VEGF165 treatment,
culture medium with a final concentration of 5 ng/ml of VEGF165
(Calbiochem, EMD Biosciences, USA) was added to wells for
6 hrs before cell fixation. After fixation and permeabilization, cells
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Cruz, US), and a CY3-conjugated secondary antibody. Specificity
of staining was assessed by substitution of nonimmune serum for
the primary antibody. Following the incubation steps suggested by
the manufacturer, cell nuclei were stained with 40,6-diamino-2-
phenylindole (DAPI; Molecular Probes, Eugene, OR). The slides
were coverslipped with anti-fading medium and examined under a
fluorescence microscope.
Co-culture Assays
Three types of co-culture model, each of which maintained the
natural anatomical relationship between basal RPE cells and
CECs, were used for proliferation, migration and tube formation
assays as previously described [19]. Briefly, for the proliferation
and tube formation assay models, RPE cells were plated in Costar
Transwells (Costar/Corning, NY) with 0.40 mm pore-size inserts,
which were put in wells where RF/6A cells were plated. In
addition, the wells for the tube formation assay were coated with
200 ml of extracellular matrix (ECM). For the migration assay,
RF/6A cells were plated in Costar Transwells (Costar/Corning,
NY) with 8.0 mm pore-size inserts, which were put in wells where
RPE cells was plated. The specific procedures for the respective
assays are described in detail below.
Proliferation assay
To test the effects of RPE cells on RF/6A cells proliferation
under hypoxic conditions, a proliferation assay model was used.
RF/6A cells were plated at a density of 4.0610
4 cells/cm
2 in 24-
well plates in complete medium, and allowed to adhere overnight.
Next, cells were transfected with Dll4, control pDNA or Si-Dll4
and treated with gamma secretase inhibitor (GSI) (EMD
Biosciences, San Diego, CA, USA) before 0.40 mm pore-size
inserts were placed in the wells. Medium containing 200 mM
CoCl2 was added and was changed every three days. Cell
proliferation was measured using a modified MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay on
days 1, 2, 3, 4, 5, 6 and 7. Briefly, 100 ml MTT was added per well
after the inserts were removed, and the RF/6A cells were
incubated for 4 hrs. The formazan crystals formed were dissolved
in 750 ml dimethyl sulfoxide after the medium was aspirated. The
solution was transferred to a 96-well plate and the optical density
value was recorded at 570 nm on a Microplate Reader (Model
680, Bio-Rad, USA). The results were expressed relative to the
OD value of the RF/6A cells monoculture on day one of the assay.
Migration assay
To test the effect of RPE cells on RF/6A cells migration under
hypoxic conditions, a migration assay model was used. RPE cells
were plated at density of 1.0610
5/cm
2 in 24-well plates and
medium containing 200 mM CoCl2 was added to the wells for
12 hrs. The RF/6A cell migration assay was performed using
matrigel-coated, Costar Transwell inserts with an 8.0 mm pore-
size. Briefly, 5.0610
4 RF/6A cells were seeded onto inserts and
incubated with DMEM containing 1% FBS. After 1 h attachment,
the inserts were transferred to 24-well plates as described above.
After incubation for 4 hrs, the inserts were fixed with 4%
paraformaldehyde and stained with hematoxylin and eosin. The
number of migrated cells was counted using phase contrast
microscopy (2006). Five randomly chosen fields were counted per
insert.
Tube formation assay
A co-culture model was used for the tube formation assay, in
which two-dimensional tube formation was measured in a collagen
gel. For this assay, 24-well plates were coated with 200 ml ECM
(Sigma-Aldrich, St. Louis, MO, USA) and incubated at 37uC for
1 h to form gels. After polymerization of the gels, 1.0610
5 RF/6A
cells were seeded into each well and incubated with 1.0 ml
DMEM containing 1% FBS. Next, inserts were placed in the wells
as described in the proliferation assay. Five different fields were
chosen randomly in each well, and photographs were taken with a
phase-contrast microscope in 24 hrs. The length of the tubes was
measured using Image-Pro Plus software (Media Cybernetics,
L.P., Silver Spring, MD, USA) and was expressed as a total length
(mm) per microscopic field for each single well.
Contact co-culture invasion assay
The RPE-CEC contact co-culture system had been described
previously [43,52]. Invasion assays were performed with 8.0 mm
pore-size Costar Transwell inserts (Costar/Corning, NY) that
permit cell migrate across the filter. 5.0610
4 RPE cells were grown
for 6 hrs on the underside of the transwell inserts to form an
organized monolayer. 5.0610
4 RF/6A cells were infected with the
Ade-GFP virus for 24 hrs before plating inside the inserts and
2.0610
5 RPE were plated in the lower well under hypoxic
conditions to provide chemoattractants. The undersides of the
filters were fixed 6 hrs after the RF/6A cells were plated, and the
migrated cells were counted under a fluorescence microscope.
Statistical analysis
Experiments were performed three times, and each experiment
was performed in triplicate. All data from quantitative assays were
Table 1. Primers for Real-time RT-PCR.
Genes Forward primer sequence Reverse primer sequence
Dll4 59-CCCTGGCAATGTACTTGTG
AT-39
59-TGGTGGGTGCAGTAGTTGAG-39
HIF-1a 59-TCGGCGAAGTAAAGAATC
TGAA-39
59-CAAATCACCAGCATCCAGAAG-
39
VEGF 59-CGCCTCTCCAAAAAGCTA
CAC-39
59-CTCACAGGAAACCGGACATC-39
VEGFR-1 59-CAGCATACCTCACTGTTC
AAGG-39
59-CCACACAGGTGCATGTTAGAG-
39
VEGFR-2 59-CGCGCCTCCTTCTAGACA-39 59-AGAAACACTAGGCAAACCCA
CA-39
EphrinB2 59-GAGCCCGGCGAACATTT
ACAT-39
59-TTCAGTCAATTCTCCAGCA
CGC-39
EphB4 59-TGGTCATTGTGGTCGCA
GTTC-39
59-CCTCACAGCCTCATTAGGGTC
TTC-39
GAPDH 59-GCGCTGAGTACGTCGTG
GAG-39
59-CAGTTGGTGGTGCAGGAGG-39
doi:10.1371/journal.pone.0018481.t001
Table 2. Primers for semi-quantitative RT-PCR.
Genes Forward primer sequence Reverse primer sequence
Dll4 59-GCTGGAAGTGGATTGTGG-39 59-CTTGTCGCTGTGAGGATAC-39
VEGF 59- AGCCCATGAAGTGGTGAA -39 59- TGCGGATCTTGGACAAAC -39
b-Actin 59-CACCCGCGAGTACAACCTTC -39 59-CCCATACCCACCATCACACC -39
doi:10.1371/journal.pone.0018481.t002
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statistically using one-way ANOVA analysis and the independent
samples t-test. P,0.01 was considered to be statistically significant.
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